You aim to evaluate the impact of molecules, medicines or treatment strategies on cognitive function during your trials ?

The services we offer


Evaluation of cognitive impairment

in patients during clinical trials, with the possibility of conducting studies specifically adapted to elderly subjects


Design and implementation of clinical studies

that focus on cognitive impairment with different types of treatments


Examination of problems

related to aging or oral treatments


Brain Imaging

(MRI, PET Scan)

“Our expertise concerns the assessment of cognitive impairment, especially with new targeted therapy, implementation of strategies for preventing and improving cognitive impairment, and monitoring cognitive function with oral therapy. Within the CNO, longitudinal, multicenter studies employ the teams from the anti-cancer centers as well as from psycho-oncology and oncogeriatric departments of Caen, Rouen and Lille.”